Trial Details
RecruitingBasic Information
| Clinical ID | c2830 |
|---|---|
| Identifier | NCT03261102 |
| Trial Title | Therapeutic Drug Monitoring Guided Early Optimization of Adalimumab in Crohn's Disease; A Randomized Open Label Study |
| Trial URL | Visit Original Page |
Study Information
| Study Results | No results available |
|---|---|
| Conditions | Crohn Disease;Drug Monitoring;Inflammatory Bowel Diseases |
| Interventions | Biological: Adalimumab |
Participant Information
| Sponsor | waqqas.afif |
|---|---|
| City | - |
| Country/Region | Canada |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | - |
Study Design
| Study Type | Interventional |
|---|---|
| Phase | Not Available |
Time Information
| Start Date | 2025-04-24 |
|---|---|
| Primary Completion Date | - |
| Completion Date | - |